1. Home
  2. THRY vs ADAG Comparison

THRY vs ADAG Comparison

Compare THRY & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thryv Holdings Inc.

THRY

Thryv Holdings Inc.

HOLD

Current Price

$3.20

Market Cap

128.1M

Sector

Industrials

ML Signal

HOLD

Logo Adagene Inc.

ADAG

Adagene Inc.

SELL

Current Price

$3.02

Market Cap

146.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
THRY
ADAG
Founded
2012
2011
Country
United States
China
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.1M
146.3M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
THRY
ADAG
Price
$3.20
$3.02
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
$9.33
$8.00
AVG Volume (30 Days)
1.8M
83.9K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
100.50
N/A
EPS
0.01
N/A
Revenue
$785,015,000.00
N/A
Revenue This Year
N/A
$3,688.61
Revenue Next Year
N/A
$17.39
P/E Ratio
$292.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.91
$1.33
52 Week High
$17.10
$3.53

Technical Indicators

Market Signals
Indicator
THRY
ADAG
Relative Strength Index (RSI) 41.18 52.29
Support Level N/A $1.64
Resistance Level $4.05 $3.19
Average True Range (ATR) 0.40 0.28
MACD -0.02 -0.07
Stochastic Oscillator 60.51 27.71

Price Performance

Historical Comparison
THRY
ADAG

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. Its company is built upon a rich legacy in the marketing and advertising industry. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable SMB clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation, and run their day-to-day operations to save time, compete and win in today's SMB environment. The group has two business segments; Thryv SaaS and Thryv Marketing Services.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: